Mannatech Gross Margin 2012-2025 | MTEX

Current and historical gross margin for Mannatech (MTEX) over the last 10 years. The current gross profit margin for Mannatech as of December 31, 2025 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Mannatech Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-12-31 $0.11B $0.08B 74.31%
2025-09-30 $0.11B $0.08B 75.68%
2025-06-30 $0.11B $0.09B 75.44%
2025-03-31 $0.12B $0.09B 75.86%
2024-12-31 $0.12B $0.09B 77.12%
2024-09-30 $0.12B $0.09B 76.23%
2024-06-30 $0.12B $0.10B 77.24%
2024-03-31 $0.13B $0.10B 78.13%
2023-12-31 $0.13B $0.10B 78.20%
2023-09-30 $0.13B $0.10B 76.87%
2023-06-30 $0.14B $0.11B 76.64%
2023-03-31 $0.14B $0.11B 76.26%
2022-12-31 $0.14B $0.10B 75.91%
2022-09-30 $0.14B $0.11B 78.17%
2022-06-30 $0.15B $0.12B 79.31%
2022-03-31 $0.15B $0.12B 78.43%
2021-12-31 $0.16B $0.13B 79.25%
2021-09-30 $0.16B $0.12B 77.99%
2021-06-30 $0.16B $0.12B 76.58%
2021-03-31 $0.15B $0.12B 77.12%
2020-12-31 $0.15B $0.12B 76.97%
2020-09-30 $0.15B $0.12B 78.29%
2020-06-30 $0.15B $0.12B 79.22%
2020-03-31 $0.16B $0.13B 80.25%
2019-12-31 $0.16B $0.13B 80.38%
2019-09-30 $0.16B $0.13B 80.37%
2019-06-30 $0.17B $0.13B 80.12%
2019-03-31 $0.17B $0.14B 80.59%
2018-12-31 $0.17B $0.14B 80.35%
2018-09-30 $0.18B $0.14B 80.00%
2018-06-30 $0.17B $0.14B 80.46%
2018-03-31 $0.18B $0.14B 80.23%
2017-12-31 $0.18B $0.14B 79.66%
2017-09-30 $0.17B $0.14B 79.89%
2017-06-30 $0.18B $0.14B 79.44%
2017-03-31 $0.18B $0.14B 79.01%
2016-12-31 $0.18B $0.14B 79.01%
2016-09-30 $0.18B $0.15B 79.23%
2016-06-30 $0.18B $0.14B 79.89%
2016-03-31 $0.18B $0.14B 80.23%
2015-12-31 $0.18B $0.15B 81.11%
2015-09-30 $0.18B $0.15B 81.11%
2015-06-30 $0.19B $0.16B 80.73%
2015-03-31 $0.19B $0.15B 80.63%
2014-12-31 $0.19B $0.15B 80.00%
2014-09-30 $0.19B $0.15B 79.17%
2014-06-30 $0.18B $0.14B 78.89%
2014-03-31 $0.18B $0.14B 78.77%
2013-12-31 $0.18B $0.14B 79.21%
2013-09-30 $0.17B $0.14B 79.77%
2013-06-30 $0.17B $0.14B 79.65%
2013-03-31 $0.17B $0.14B 79.53%
2012-12-31 $0.17B $0.14B 79.31%
2012-09-30 $0.18B $0.14B 79.44%
2012-06-30 $0.19B $0.13B 69.15%
2012-03-31 $0.20B $0.12B 59.49%
2011-12-31 $0.20B $0.10B 50.75%
2011-09-30 $0.21B $0.09B 42.31%
2011-06-30 $0.21B $0.09B 42.92%
2011-03-31 $0.22B $0.10B 43.38%
2010-12-31 $0.23B $0.10B 42.79%
2010-09-30 $0.24B $0.10B 41.80%
2010-06-30 $0.26B $0.10B 39.23%
2010-03-31 $0.28B $0.10B 34.29%
2009-12-31 $0.29B $0.10B 33.10%
2009-09-30 $0.30B $0.10B 33.78%
2009-06-30 $0.30B $0.11B 36.30%
2009-03-31 $0.31B $0.12B 39.42%
2008-12-31 $0.33B $0.13B 40.36%
2008-09-30 $0.36B $0.14B 39.44%
2008-06-30 $0.37B $0.15B 38.77%
2008-03-31 $0.40B $0.16B 39.10%
2007-12-31 $0.41B $0.16B 39.47%
2007-09-30 $0.42B $0.17B 40.14%
2007-06-30 $0.42B $0.17B 40.57%
2007-03-31 $0.42B $0.17B 41.49%
2006-12-31 $0.41B $0.17B 41.12%
2006-09-30 $0.41B $0.17B 41.73%
2006-06-30 $0.41B $0.17B 41.48%
2006-03-31 $0.40B $0.16B 40.45%
2005-12-31 $0.39B $0.16B 40.87%
2005-09-30 $0.37B $0.15B 40.05%
2005-06-30 $0.35B $0.14B 39.71%
2005-03-31 $0.32B $0.13B 40.19%
2004-12-31 $0.29B $0.12B 40.14%
2004-09-30 $0.26B $0.11B 40.53%
2004-06-30 $0.24B $0.10B 41.10%
2004-03-31 $0.21B $0.09B 42.11%
2003-12-31 $0.19B $0.08B 42.41%
2003-09-30 $0.18B $0.07B 42.29%
2003-06-30 $0.16B $0.07B 42.14%
2003-03-31 $0.15B $0.06B 41.50%
2002-12-31 $0.14B $0.06B 40.71%
2002-09-30 $0.13B $0.05B 39.55%
2002-06-30 $0.13B $0.05B 40.00%
2002-03-31 $0.13B $0.05B 40.63%
2001-12-31 $0.13B $0.05B 41.86%
2001-09-30 $0.13B $0.06B 41.98%
2001-06-30 $0.14B $0.06B 41.30%
2001-03-31 $0.14B $0.06B 41.67%
2000-12-31 $0.15B $0.06B 40.67%
2000-09-30 $0.16B $0.07B 41.98%
2000-06-30 $0.17B $0.07B 42.69%
2000-03-31 $0.18B $0.08B 42.37%
1999-12-31 $0.18B $0.08B 42.78%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.011B $0.118B
Mannatech Inc is a wellness solution provider that sells its products through a global network-marketing system throughout the United States and the international markets of Canada, Australia, the United Kingdom, Japan and New Zealand.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.845B 31.38
UCB SA (UCBJY) Belgium $60.713B 0.00
Takeda Pharmaceutical (TAK) Japan $57.538B 11.30
Zoetis (ZTS) United States $49.577B 18.36
Sandoz Group AG (SDZNY) Switzerland $37.136B 0.00
Otsuka Holdings, - (OTSKY) Japan $36.393B 14.73
BeOne Medicines - (ONC) Switzerland $33.976B 83.02
Daiichi Sankyo, - (DSNKY) Japan $33.284B 16.12
Astellas Pharma (ALPMY) Japan $29.805B 11.68
United Therapeutics (UTHR) United States $25.058B 20.49
Shionogi (SGIOY) Japan $18.069B 13.97
Merck (MKKGY) Germany $16.944B 11.65
IPSEN (IPSEY) France $16.273B 0.00
Summit Therapeutics (SMMT) United States $15.264B 0.00
Neurocrine Biosciences (NBIX) United States $12.936B 27.96
Ionis Pharmaceuticals (IONS) United States $12.417B 0.00
Madrigal Pharmaceuticals (MDGL) United States $11.920B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.749B 16.23
Orion OYJ (ORINY) Finland $10.723B 18.62
Eisai (ESAIY) $9.158B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.834B 16.35
Centessa Pharmaceuticals (CNTA) United Kingdom $6.102B 0.00
Grifols, S.A (GRFS) Spain $5.588B 0.00
Corcept Therapeutics (CORT) United States $4.458B 51.11
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Stevanato Group S.p.A (STVN) Italy $4.094B 22.53
NewAmsterdam Pharma (NAMS) Netherlands $3.997B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.945B 16.50
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $3.838B 0.00
Indivior Pharmaceuticals (INDV) United States $3.724B 12.41
Hypermarcas (HYPMY) Brazil $3.308B 13.82
Dyne Therapeutics (DYN) United States $3.086B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.046B 9.86
Oruka Therapeutics (ORKA) United States $2.952B 0.00
Soleno Therapeutics (SLNO) United States $2.717B 228.83
Enliven Therapeutics (ELVN) United States $2.710B 0.00
Relay Therapeutics (RLAY) United States $2.670B 0.00
Guardian Pharmacy Services (GRDN) United States $2.479B 41.65
BioCryst Pharmaceuticals (BCRX) United States $2.398B 7.19
Nektar Therapeutics (NKTR) United States $2.223B 0.00
Definium Therapeutics (DFTX) United States $2.147B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.096B 19.46
Ocular Therapeutix (OCUL) United States $1.914B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.808B 0.00
Ardelyx (ARDX) United States $1.516B 0.00
Harrow (HROW) United States $1.338B 79.84
Savara (SVRA) United States $1.158B 0.00
Collegium Pharmaceutical (COLL) United States $1.149B 5.37
Xeris Biopharma Holdings (XERS) United States $1.009B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cronos Group (CRON) Canada $0.971B 0.00
Evotec AG (EVO) Germany $0.935B 0.00
Xencor (XNCR) United States $0.911B 0.00
Aktis Oncology (AKTS) United States $0.901B 0.00
Theravance Biopharma (TBPH) United States $0.842B 21.80
ARS Pharmaceuticals (SPRY) United States $0.799B 0.00
Relmada Therapeutics (RLMD) United States $0.765B 0.00
Bioventus (BVS) United States $0.753B 13.32
Ironwood Pharmaceuticals (IRWD) United States $0.592B 15.78
ProKidney (PROK) United States $0.589B 0.00
Esperion Therapeutics (ESPR) United States $0.557B 0.00
Zevra Therapeutics (ZVRA) United States $0.556B 9.19
Rigel Pharmaceuticals (RIGL) United States $0.540B 4.49
Lyell Immunopharma (LYEL) United States $0.522B 0.00
Larimar Therapeutics (LRMR) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.501B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
Aclaris Therapeutics (ACRS) United States $0.487B 0.00
Nature's Sunshine Products (NATR) United States $0.471B 21.37
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
Altimmune (ALT) United States $0.422B 0.00
Elite Pharmaceuticals (ELTP) United States $0.409B 37.99
Century Therapeutics (IPSC) United States $0.404B 0.00
Akebia Therapeutics (AKBA) United States $0.375B 0.00
USANA Health Sciences (USNA) United States $0.334B 9.43
AleAnna (ANNA) United States $0.333B 124.75
Surrozen (SRZN) United States $0.324B 0.00
Siga Technologies (SIGA) United States $0.312B 14.06
Avalo Therapeutics (AVTX) United States $0.311B 0.00
Organogenesis (ORGO) United States $0.306B 8.81
Silence Therapeutics (SLN) United Kingdom $0.271B 0.00
Cybin (HELP) Canada $0.270B 0.00
Protara Therapeutics (TARA) United States $0.268B 0.00
Prelude Therapeutics (PRLD) United States $0.257B 0.00
Minerva Neurosciences (NERV) United States $0.238B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.230B 0.00
MediWound (MDWD) Israel $0.229B 0.00
Context Therapeutics (CNTX) United States $0.229B 0.00
Enlivex (ENLV) Israel $0.228B 0.00
Inhibikase Therapeutics (IKT) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
OmniAb (OABI) United States $0.213B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Korro Bio (KRRO) United States $0.183B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.174B 0.00
Unicycive Therapeutics (UNCY) United States $0.167B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.167B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Cardiol Therapeutics (CRDL) Canada $0.154B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
VAXART, INC (VXRT) United States $0.152B 10.50
Galectin Therapeutics (GALT) United States $0.151B 0.00
Karyopharm Therapeutics (KPTI) United States $0.147B 0.00
Journey Medical (DERM) United States $0.141B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.115B 0.00
Aldeyra Therapeutics (ALDX) United States $0.107B 0.00
Pyxis Oncology (PYXS) United States $0.107B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.088B 0.00
PolyPid (PYPD) Israel $0.082B 0.00
Nuo Therapeutics (AURX) $0.082B 0.00
Champions Oncology (CSBR) United States $0.080B 0.00
Gain Therapeutics (GANX) United States $0.076B 0.00
NRx Pharmaceuticals (NRXP) United States $0.073B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Acrivon Therapeutics (ACRV) United States $0.060B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Nutriband (NTRB) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 34.33
SCYNEXIS (SCYX) United States $0.045B 0.00
Lite Strategy (LITS) United States $0.042B 0.00
Telomir Pharmaceuticals (TELO) United States $0.042B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Incannex Healthcare (IXHL) Australia $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Plus Therapeutics (PSTV) United States $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.029B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Jupiter Neurosciences (JUNS) United States $0.014B 0.00
Wellgistics Health (WGRX) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Traws Pharma (TRAW) United States $0.012B 0.02
Ainos (AIMD) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.011B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
BioVie (BIVI) United States $0.010B 0.00
BioLineRx (BLRX) Israel $0.010B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Liminatus Pharma (LIMN) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00